SE7810577L - Sett att framstella platinakoordinationsforeningar och anvendning derav inom cancerkemoterapin - Google Patents

Sett att framstella platinakoordinationsforeningar och anvendning derav inom cancerkemoterapin

Info

Publication number
SE7810577L
SE7810577L SE7810577A SE7810577A SE7810577L SE 7810577 L SE7810577 L SE 7810577L SE 7810577 A SE7810577 A SE 7810577A SE 7810577 A SE7810577 A SE 7810577A SE 7810577 L SE7810577 L SE 7810577L
Authority
SE
Sweden
Prior art keywords
platina
associations
coordination
way
cancer therapy
Prior art date
Application number
SE7810577A
Other languages
English (en)
Inventor
M J Cleare
J D Hoeschele
B Rosenberg
Camp L L Van
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22991508&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE7810577(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Corp filed Critical Research Corp
Publication of SE7810577L publication Critical patent/SE7810577L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
SE7810577A 1972-06-08 1978-10-10 Sett att framstella platinakoordinationsforeningar och anvendning derav inom cancerkemoterapin SE7810577L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26098972A 1972-06-08 1972-06-08

Publications (1)

Publication Number Publication Date
SE7810577L true SE7810577L (sv) 1978-10-10

Family

ID=22991508

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7308050A SE415182B (sv) 1972-06-08 1973-06-07 Sett att framstella platinakoordinationsforeningar
SE7810577A SE7810577L (sv) 1972-06-08 1978-10-10 Sett att framstella platinakoordinationsforeningar och anvendning derav inom cancerkemoterapin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7308050A SE415182B (sv) 1972-06-08 1973-06-07 Sett att framstella platinakoordinationsforeningar

Country Status (9)

Country Link
US (1) US4140707A (sv)
JP (1) JPS5629676B2 (sv)
CA (1) CA1023759A (sv)
CH (2) CH605550A5 (sv)
DE (1) DE2329485C3 (sv)
FR (1) FR2187345B1 (sv)
GB (1) GB1380228A (sv)
NL (2) NL183724C (sv)
SE (2) SE415182B (sv)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258051A (en) * 1975-01-10 1981-03-24 Research Corporation Method of treating viral infections
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
US4440782A (en) * 1977-03-01 1984-04-03 Research Corporation Method of treating viral infections
US4225529A (en) * 1977-10-19 1980-09-30 Johnson, Matthey & Co., Limited Compositions containing platinum
US4203912A (en) * 1977-10-19 1980-05-20 Johnson, Matthey & Co., Limited Compositions containing platinum
US4230631A (en) * 1977-10-19 1980-10-28 Johnson, Matthey & Co., Limited Platinum coordination compounds
SE7903359L (sv) * 1978-04-20 1979-10-21 Johnson Matthey Co Ltd Kompositioner innehallande platina
GB2019405A (en) * 1978-04-20 1979-10-31 Johnson Matthey & Co Ltd Pt Pt (II) and (IV) Amino-Acid Complexes
SE7903361L (sv) * 1978-04-20 1979-10-21 Johnson Matthey Co Ltd Kompositioner innehallande platina
NL7807334A (nl) * 1978-07-06 1980-01-08 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
JPS6034958B2 (ja) * 1978-09-02 1985-08-12 喜徳 喜谷 新規白金錯体
US4291027A (en) * 1979-03-07 1981-09-22 Engelhard Minerals & Chemicals Corp. Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
US4234500A (en) * 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
US4462998A (en) * 1979-06-20 1984-07-31 Engelhard Corporation Method of using a cis-platinum(II) amine ascorbate
US4271085A (en) * 1979-06-20 1981-06-02 Engelhard Minerals & Chemicals Corporation Cis-platinum (II) amine lactate complexes
US4505928A (en) * 1979-06-20 1985-03-19 Engelhard Corporation Pharmaceutical composition containing cis-platinum (II) amine lactate and a method of using same
US4457926A (en) * 1979-06-20 1984-07-03 Engelhard Corporation Cis-Platinum(II) amine ascorbate complexes
US4284579A (en) * 1979-07-17 1981-08-18 The United States Of America As Represented By The Of The Department Of Health & Human Services (N-Phosphonacetyl-L-aspartato)(1,2-diaminocyclchexane)platinum(II) or alkali metal salt
ZA805101B (en) * 1979-08-23 1981-08-26 Johnson Matthey Co Ltd Compositions containing platinium
NL181434C (nl) * 1980-01-03 1987-08-17 Tno Platina(iv)-diamine-complexen, alsmede hun bereiding en toepassing.
GR75598B (sv) * 1980-04-29 1984-08-01 Sanofi Sa
JPS56154493A (en) * 1980-04-30 1981-11-30 Shionogi & Co Ltd Novel platinum complex
US4322362A (en) * 1980-07-28 1982-03-30 Bristol-Myers Company Salts of 2-hydroxymalonate platinum complexes
AU538863B2 (en) * 1980-05-27 1984-08-30 Bristol-Myers Company Platinum complex salts have anti-tumor property
US4428943A (en) 1980-06-09 1984-01-31 The United States Of America As Represented By The Department Of Health And Human Services (N-Phosphonacetyl-L-aspartato) (1,2-diaminocyclohexane)platinum(II) or alkali metal salt
JPS5851959B2 (ja) * 1980-06-11 1983-11-19 呉羽化学工業株式会社 プラチナ化合物とその医薬組成物
JPS5716895A (en) * 1980-07-05 1982-01-28 Otsuka Chem Co Ltd Platinum 2 complex and antitumor agent containing the same as active principle
JPS57123198A (en) * 1981-01-23 1982-07-31 Shionogi & Co Ltd Novel platinum complex
JPS5896024A (ja) * 1981-10-16 1983-06-07 リチヤ−ド・エフ・ストツケル 白金毒解毒剤
US4500465A (en) * 1982-06-28 1985-02-19 Engelhard Corporation Solubilized platinum (II) complexes
US4584392A (en) * 1982-11-10 1986-04-22 Inco Alloys International, Inc. Platinum and palladium complexes
US4560782A (en) * 1982-11-19 1985-12-24 Research Corporation Anti-tumor diplatinum coordination compounds
IL67789A (en) * 1983-01-31 1986-09-30 Yissum Res Dev Co Amino-substituted malonato platinum(ii)complexes and method for their preparation
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
US4906646A (en) * 1983-03-31 1990-03-06 Board Of Governors Of Wayne State University Method and composition for the treatment of tumors by administering a platinum coordination compound and a calcium channel blocker compound of the dihydropyridine class
US4617189A (en) * 1983-04-14 1986-10-14 Stockel Richard F Use of selenium-containing compounds for negating the toxic effects of platinum compounds used in chemotherapy, and a novel selenium-containing platinum compound and use thereof as an anti-cancer medicine
JPS59222498A (ja) * 1983-06-01 1984-12-14 Shionogi & Co Ltd 新規グリコ−ル酸系白金錯体および抗悪性腫瘍剤
US4758588A (en) * 1983-06-20 1988-07-19 Research Corporation Technologies Diaminocyclohexane platinum complexes
US4661516A (en) * 1983-06-20 1987-04-28 Research Corporation Diaminocyclohexane platinum complexes
GR82129B (sv) * 1983-06-20 1984-12-13 Research Corp
EP0136012B1 (en) * 1983-08-05 1989-04-19 Yoshinori Kidani Cytostatic platinum complexes
GB8328218D0 (en) * 1983-10-21 1983-11-23 Johnson Matthey Plc Oral compositions
DE3490640C2 (de) * 1984-01-23 1990-04-19 Inst Obschei I Neoorganichesko Platin (II)-Carboxylatokomplexe und Verfahren zu ihrer Herstellung
US4843161A (en) * 1984-06-01 1989-06-27 Massachusetts Institute Of Technology Platinum-intercalative complexes for the treatment of cancer
GB8416048D0 (en) * 1984-06-22 1984-07-25 Johnson Matthey Plc Anti-tumour compounds of platinum
EP0169645A1 (en) * 1984-06-27 1986-01-29 Johnson Matthey Public Limited Company Platinum co-ordination compounds
US4645661A (en) * 1984-06-29 1987-02-24 St. Jude Children's Research Hospital Method for alleviating cisplatin-induced nephrotoxicity and dithiocarbamate compounds for effecting same
ES8801168A1 (es) * 1984-11-02 1987-02-16 Johnson Matthey Plc Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
US4588831A (en) * 1984-11-09 1986-05-13 Natec Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use
US4665210A (en) * 1984-12-17 1987-05-12 American Cyanamid Company Platinum complexes of aliphatic tricarboxylic acids
ZA86704B (en) * 1985-02-23 1986-10-29 Asta Werke Ag Chem Fab Tumor retarding(1-benzyl-ethylenediamine9-platin(ii)-complexes
CA1274529A (en) * 1985-09-05 1990-09-25 Federico Sampedro Platinum(ii) complexes of 1,1-cyclobutane- dicarboxylate and process for their production
US4658047A (en) * 1985-09-27 1987-04-14 The United States Of America As Represented By The Department Of Health And Human Services Method of preparing 1,2-diaminocyclohexane tetrachloro platinum (IV) isomers
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US4670458A (en) * 1986-01-31 1987-06-02 American Cyanamid Company Hydroxylated 1,2-diaminocyclohexane platinum complexes
US4760157A (en) * 1986-01-31 1988-07-26 American Cyanamid Company (2,2,-bis(aminomethyl)-1,3-propanediol-N,N')platinum complexes
CS269719B1 (en) * 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
US5434256A (en) * 1988-11-22 1995-07-18 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US6884418B1 (en) 1989-08-04 2005-04-26 Berlex Laboratories, Inc. Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
AU5878294A (en) * 1994-02-07 1995-08-21 Kiss Laboratories S.R.O. Anti-tumour medical preparation on the basis of carboplatin and the method of its production
US5922689A (en) * 1995-09-11 1999-07-13 Unitech Pharmaceuticals, Inc. Cisplatin analogs for cancer treatment
JP3154399B2 (ja) * 1996-07-04 2001-04-09 デビオファーム エス．アー． 白金化合物の製造方法
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
CN1068002C (zh) * 1997-04-30 2001-07-04 中国科学院大连化学物理研究所 铂抗癌药物及合成
CN1140272C (zh) * 1998-04-03 2004-03-03 味之素株式会社 抗肿瘤剂
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AU1608801A (en) 1999-11-15 2001-05-30 Parker Hughes Institute Diamino platinum (ii) antitumor complexes
US6545010B2 (en) * 2000-03-17 2003-04-08 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
DE60127970T2 (de) * 2000-06-30 2007-12-20 Eli Lilly And Co., Indianapolis Zusammensetzung, welche ein antifolate und ein methylmalonsäuresenkendes mittel enthält
DE10032256C2 (de) * 2000-07-03 2003-06-05 Infineon Technologies Ag Chip-ID-Register-Anordnung
TWI315982B (en) 2001-07-19 2009-10-21 Novartis Ag Combinations comprising epothilones and pharmaceutical uses thereof
EP1435965A4 (en) * 2001-09-26 2005-09-21 Intermune Inc PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
AU2003251955A1 (en) * 2002-07-16 2004-02-02 Sonus Pharmaceuticals, Inc. Platinum compound
US7160908B2 (en) * 2003-03-04 2007-01-09 Unitech Pharmaceuticals, Inc. Dynamic anticancer platinum compounds
WO2005090372A2 (en) * 2004-03-15 2005-09-29 Sonus Pharmaceuticals, Inc. Platinum carboxylate anticancer compounds
US20080161251A1 (en) 2005-01-21 2008-07-03 Astex Therapeutics Limited Pharmaceutical Compounds
WO2006103691A1 (en) * 2005-03-28 2006-10-05 Dabur Pharma Ltd. Stable pharmaceutical compositions of platinum (ii) antitumour agents
WO2007128820A1 (en) 2006-05-09 2007-11-15 Novartis Ag Combination comprising an iron chelator and an anti-neoplastic agent and use thereof
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
PT2845866T (pt) 2006-10-27 2017-08-09 Genentech Inc Anticorpos e imunoconjugados e utilizações dos mesmos
NZ586053A (en) 2007-11-09 2012-09-28 Peregrine Pharmaceuticals Inc Anti-vegf antibody compositions and methods
EP2644204B1 (en) 2008-03-18 2017-04-19 Genentech, Inc. Combinations of an Anti-HER2 antibody-drug conjugate and pertuzumab
JP5581200B2 (ja) 2008-03-27 2014-08-27 大鵬薬品工業株式会社 シチジン誘導体及びカルボプラチンを含有する抗腫瘍剤
JP4664424B2 (ja) * 2008-09-03 2011-04-06 ユニーテック株式会社 白金錯体及びそれを含む医薬組成物
WO2010104035A1 (ja) 2009-03-12 2010-09-16 学校法人近畿大学 非小細胞肺癌に対する化学療法の治療効果予測方法
RS56759B1 (sr) 2011-04-01 2018-04-30 Genentech Inc Kombinacija akt inhibitor jedinjenja i abiraterona za upotrebu pri terapeutskim tretiranjima
EP2508525A1 (en) 2011-04-05 2012-10-10 Bayer Pharma Aktiengesellschaft Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
JP5179628B2 (ja) 2011-07-15 2013-04-10 ユニーテック株式会社 ４価白金錯体及びそれを含む医薬組成物
SG10201706196XA (en) 2012-06-08 2017-08-30 Hoffmann La Roche Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
WO2017097986A1 (en) 2015-12-09 2017-06-15 Medizinische Universität Wien Monomaleimide-functionalized platinum compounds for cancer therapy
WO2017192290A1 (en) 2016-05-04 2017-11-09 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs
CN107773556B (zh) * 2016-08-26 2020-08-18 广州安好医药科技有限公司 一种具有抗肿瘤药物功效的联合用药物
SG11201909218RA (en) 2017-04-03 2019-11-28 Hoffmann La Roche Antibodies binding to steap-1

Also Published As

Publication number Publication date
NL183724B (nl) 1988-08-01
CH605550A5 (sv) 1978-09-29
DE2329485C3 (de) 1980-07-31
DE2329485A1 (de) 1973-12-20
CH588505A5 (sv) 1977-06-15
US4140707A (en) 1979-02-20
CA1023759A (en) 1978-01-03
NL930049I1 (nl) 1993-09-01
GB1380228A (en) 1975-01-08
NL930049I2 (nl) 1993-11-16
US4140707B1 (sv) 1989-12-19
NL183724C (nl) 1989-01-02
NL7307863A (sv) 1973-12-11
FR2187345A1 (sv) 1974-01-18
JPS4948621A (sv) 1974-05-11
DE2329485B2 (de) 1979-11-22
FR2187345B1 (sv) 1976-12-31
SE415182B (sv) 1980-09-15
JPS5629676B2 (sv) 1981-07-09

Similar Documents

Publication Publication Date Title
SE7810577L (sv) Sett att framstella platinakoordinationsforeningar och anvendning derav inom cancerkemoterapin
SE396093B (sv) Segjern och sett att framstella detta
SE407670C (sv) Sett att svetsa och medel herfor
SE7605369L (sv) Kulsintringsapparat och sett att framstellla kulsinter
TR19236A (tr) Toprak islemede yueksek mukavemetli nuefuz edici dis
SE408719B (sv) Sett och apparat for palning
BE796979A (fr) Copolyesters segmentes modifies et leur preparation
SE396449B (sv) Blindnitsenhet och sett att tillveka densamma
BE795907A (fr) 2-amino-4-arylthiazoles 5-substitues et leur preparation
BE800781A (fr) Oxathiazinones et leur preparation
BE797101A (fr) Chlorothiazoles et leur preparation
SE388214B (sv) Sett att framstella ferrokisel i en elektrisk ljusbagsugn
SE388635B (sv) Sett att behandla staltrad i dess slutliga dimension
IT994414B (it) Perfezionamento nei magnetron
BE771531A (fr) Aerosolklep en sproeikop
SE373578B (sv) Sett att framstella steroidooxazolidiner och steroido-oxazolidino-oxaziner
SE410462B (sv) Sett att disproportionera hydrosilanestrar till legre silaner och silanestrar
BE797806A (fr) Polyamides transparents et leur preparation
SE7603122L (sv) Dibensazeciner och sett att framstella desamma
SE391119B (sv) Biomedicinsk elektrod
SE391836B (sv) Elektrisk volframhalogenglodlampa och sett att framstella densamma
SE420611B (sv) Berarfixerad makromolekyler forening och sett att framstella densamma
IT1002543B (it) Maglieria in catena e procedimento per produrla
BE791468A (fr) Polyamides transparents et leur preparation
BE784828A (fr) Antihalolagen in fotografisch materiaal